25 research outputs found

    Cultural Antecedents to Community: An Evaluation of Community Experience in the United States, Thailand, and Vietnam

    Full text link
    To what extent does community experience differ between low‐context and high‐context societies? Prior literature theorizes that community experience consists of two separate, yet highly related concepts: community attachment, an individual’s general rootedness to a place, and community satisfaction, how well an individual’s community meets their societal needs. We test this conceptualization of community experience across communities in the United States and two Southeast Asian nations: Thailand and Vietnam. We argue that Southeast Asian nations constitute “high‐context” societies with relatively high social integration and solidarity while the United States is more individualized and less socially integrated and thus constitutes a “low‐context” society. Our results provide empirical evidence that individuals’ experience of community varies between low‐ and high‐context societies. These results demonstrate that cultural context continues to matter in regards to the lived experience of community and researchers need to remain vigilant in accounting for such differences as they seek to examine the concept of community more broadly.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/144606/1/cico12300.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/144606/2/cico12300-sup-0001-CommAppendices.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/144606/3/cico12300_am.pd

    Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Duloxetine and venlafaxine extended release (venlafaxine XR) are SNRIs indicated for the treatment of MDD. This study addresses whether duloxetine and venlafaxine XR are interchangeable in their patterns of use with patients who are depressed or are used more selectively based on treatment history, background characteristics, and presenting symptoms.</p> <p>Methods</p> <p>This was a retrospective analysis of an administrative insurance claims database. We studied patients in managed care with major depressive disorder (MDD) treated with duloxetine or venlafaxine XR. Predictors of treatment and cost were assessed using Chi-square and logistic regression analyses of demographics and past-year medication use and comorbidities.</p> <p>Results</p> <p>Patients with MDD treated with duloxetine (n = 9,641) versus venlafaxine XR (n = 8,514) tended to be older, slightly more likely to be female, and treated by a psychiatrist (<it>P </it>< 0.0001). In the prior year, more duloxetine patients (vs. venlafaxine XR) received ≄3 unique antidepressants (20.8% vs. 16.6%), ≄3 unique pain medications (25.5% vs. 15.6%), and had ≄8 unique diagnosed comorbid medical and psychiatric conditions (38.6% vs. 29.1%). The prior 6-month total health care costs were $1,731 higher for duloxetine than for venlafaxine XR and declined for both medications in the 6 months after treatment began. Logistic regression analysis revealed that 61% of duloxetine patients and 61% of venlafaxine XR patients were predictable from prior patient and treatment factors.</p> <p>Conclusions</p> <p>Patients with MDD treated with duloxetine tended to have a more complex and costly antecedent clinical presentation compared with venlafaxine XR patients, suggesting that physicians do not use the medications interchangeably.</p
    corecore